Homeopathic treatment for Epstein-Barr virus fatigue
Part of Infections clinical trials.
This study tests a homeopathic treatment (2LEBV® and 2LXFS®) for people with Epstein-Barr virus infection who experience long-lasting fatigue and other symptoms. It aims to see if this treatment helps reduce fatigue and improve overall well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years old or older.
- You must have had fatigue for at least one month.
- You must have at least two other symptoms like fever, sore throat, swollen glands, or muscle aches.
- You must have a positive blood test for Epstein-Barr virus (EBV).
- You must not be on immunosuppressive drugs, immunotherapy, or participating in other clinical trials.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks health outcomes over time in people who have a high level of the EBV virus in their blood. It may help researchers understand what happens in chronic (long-lasting) EBV infection and which outcomes to watch for.
This study looks at why fatigue doesn't go away after an EBV infection. It tests people who are early in their illness to understand the mechanisms.
This study looks at how the immune system’s antibodies behave after a first-time EBV infection, including whether they mistakenly react with the body’s own tissues. You might be offered a chance to help doctors understand why some people get longer or more intense symptoms from infectious mononucleosis.
This is an early-stage study testing a new immune-based treatment for people with conditions caused by the Epstein-Barr virus (EBV), such as chronic active EBV or post-transplant lymphoproliferative disease. The study aims to see if the treatment is safe and can help control the disease.
This study tests two experimental vaccines (V350A and V350B) designed to prevent Epstein-Barr virus infection. It is looking for healthy adolescents and adults to see if the vaccines are safe and produce a good immune response.
This trial uses donated umbilical cord blood (a type of stem cell transplant) to treat people with serious illnesses caused by the Epstein-Barr virus. It's an option for those whose disease has not responded to other treatments.
Hear when a new EBV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.